Stay updated on DLL3-Expressing Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.

Latest updates to the DLL3-Expressing Advanced Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows Revision: v3.4.2 replacing Revision: v3.4.1, which appears to be a minor site maintenance update with no impact on the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe study status on the page changed to Active, not recruiting, and several investigator/site contact details were removed.SummaryDifference4%

- Check27 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now includes a Show glossary option and updates to footer text, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; this appears to be a minor metadata/version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations have been reorganized under a single 'Locations' heading and list participating states (CA, CO, MA, MI, NY, OH, OR, TN, WI). The revision is updated to v3.3.3.SummaryDifference0.7%

- Check91 days agoChange DetectedThe Revision label changed from v3.2.0 to v3.3.2; no user-visible content or functionality was affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to DLL3-Expressing Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.